Ascendis Pharma

ASND

Market cap $12.7B

Overview Fund Trends Analyst Outlook Journalist POV

Buy

Hold

Sell

9 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

Avg. target

$260

24% upside

High target

9 analyst ratings

positive

0 neutral

0%

negative

Analyst & Firm	Rating	Price Target	Upside Downside	Date
Cantor Fitzgerald Li Watsek 71% 1-yr ASND win rate				13 Oct ‘25 3 days ago
JP Morgan Jessica Fye 56% 1-yr ASND win rate				9 Oct ‘25 7 days ago
BofA Securities Tazeen Ahmad 67% 1-yr ASND win rate				2 Sep ‘25 1 month ago
Citigroup David Lebowitz 100% 1-yr ASND win rate				8 Aug ‘25 2 months ago
RBC Capital Luca Issi 100% 1-yr ASND win rate				8 Aug ‘25 2 months ago
Wedbush Yun Zhong 100% 1-yr ASND win rate				8 Aug ‘25 2 months ago
UBS Eliana Merle 100% 1-yr ASND win rate				8 Aug ‘25 2 months ago
Wells Fargo Derek Archila 100% 1-yr ASND win rate				8 Aug ‘25 2 months ago
Stifel Alex Thompson 100% 1-yr ASND win rate				8 Aug ‘25 2 months ago